Physician profile
Mark E Rupp
NPI 1821045154
$76,124.89
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,209 · 2020: $14K · 2021: $8,208 · 2022: $16K · 2023: $19K · 2024: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Consulting Fee: $12K · Travel and Lodging: $3,186 · Food and Beverage: $185.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,175.00 |
| Consulting Fee | $12,206.25 |
| Travel and Lodging | $3,185.91 |
| Food and Beverage | $184.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $43,154.03 | 2019-2024 | Arrow |
| Kci USA, INC. | $27,200.00 | 2020-2023 | Tegaderm, 3m Cavilon, Comply |
| Bard Access Systems, INC. | $5,205.59 | 2020 | |
| Becton, Dickinson and Company | $320.00 | 2021 | |
| Teleflex Medical Canada INC. | $122.32 | 2023 | Arrow |
| Astellas Pharma US INC | $109.98 | 2019 | |
| Horizon Therapeutics Plc | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Rupp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.